What Medications Can You Not Take With Tirzepatide? (October 2026)

01

What you cannot take, and what you can only take with adjustment

The honest answer is that very few medicines are simply forbidden, while several need a plan. Your prescriber needs to know about everything you take, especially warfarin or other narrow-margin medicines, insulin and sulfonylureas.¹ The reason is mechanical. Tirzepatide slows how quickly the stomach empties, so some oral medicines can be absorbed differently, particularly when you start treatment or increase the dose.¹³

That means the real question is rarely 'is this banned?' and more often 'does this medicine need a check, a dose change, or a different back-up method?'

For any other medicine, ask your prescriber or pharmacist, and read the patient leaflet.¹³ Our related guide on medicines to avoid with GLP-1 treatment covers the wider class.

02

What to do if you already take other medicines

Make a full list before you start, including prescriptions, over-the-counter products, inhalers, patches and supplements. Include the dose and when you take each one. Do not stop or change any prescribed medicine on your own, and do not adjust insulin or tablets for diabetes without the team who prescribes them.

If you are considering treatment, our free online consultation asks about your current medicines, and a GPhC-registered prescriber reviews your answers before anything is approved.

Already on treatment and starting something new? Tell your prescriber before the next dose, and tell any pharmacist or doctor you are on tirzepatide each time. Our wider weight loss clinic page explains the full pathway, including ongoing monthly reviews. If you are not sure whether you are suitable at all, see who should not take Mounjaro in our guide to who should avoid Mounjaro.

Related guides: What medications can you not take with glp 1 and What medicine should you not take with mounjaro and Who should not take glp 1 drugs.

03 · Why interactions happen

Why tirzepatide interacts with other medicines

Most interactions come from a single effect: tirzepatide slows how quickly the stomach empties. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹ It activates two natural gut-hormone receptors at once, GIP and GLP-1, and together these help regulate appetite, slow stomach emptying and improve the way the body responds to insulin.

Because of that slower emptying, it can affect how quickly some oral medicines are absorbed. The effect is most relevant when you start treatment or increase the dose. This is why your prescriber may ask you to take extra care with timing or monitoring around each dose step.¹³

It helps to separate two types of interaction. The first is absorption: a tablet you swallow may reach your bloodstream a little later or less predictably. For most medicines that makes little practical difference. For a medicine where the effective dose sits close to the harmful dose, or where a missed effect matters a great deal, it deserves attention.

The second is additive effect: tirzepatide improves how the body responds to insulin, so medicines that also lower blood sugar can add to that effect. That is the reason insulin and sulfonylureas are named specifically.¹

What this does not mean is that you need to fear every tablet in the cupboard. It asks for openness: tell your prescriber about everything you take, and let them judge what needs adjusting. A GPhC-registered prescriber can look at your full list, spot the medicines where timing or dose matters and plan around them.

Tirzepatide also stays in the body for some time after your final dose. It has a half-life of about five days, so it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears. So if you stop treatment, keep your prescriber informed about interactions during that period too, particularly for diabetes medicines you may be about to restart at a previous dose.

04 · Insulin and sulfonylureas

Insulin and sulfonylureas: the main dose-adjustment warning

Insulin and sulfonylureas are the medicines where doses may need reducing to avoid low blood sugar.¹ This does not mean you cannot take tirzepatide with them. It means the combination needs planning with whoever prescribes your diabetes treatment.

Tirzepatide improves the way the body responds to insulin. If you are already taking medicines that push blood sugar down, the combined effect can be stronger than either alone. Low blood sugar can make you shaky, sweaty or confused. Learn the warning signs, and know what your diabetes team has told you to do if they appear.

It is worth being precise about wording here. You will sometimes see claims that these medicines 'must not be combined' with Mounjaro. That is not the case. The instruction is that doses may need adjusting. In practice, a prescriber may lower the insulin or sulfonylurea dose when tirzepatide starts, and review it again as the Mounjaro dose steps up through titration.

Do not make those changes yourself. Reducing insulin too far can leave blood sugar high; leaving it unchanged can leave you at risk of lows. Both errors are avoidable if the person managing your diabetes knows your treatment plan.

If you have type 2 diabetes and are considering private treatment for weight management, tell the consultation that you take diabetes medicines and which ones. Name each medicine, the dose and who prescribes it. A GPhC-registered prescriber reviews that information.

Practical points to raise with your prescriber:

• Which glucose-lowering medicines you take, and whether any are insulin or a sulfonylurea.
• Whether you have had low blood sugar episodes before.
• How often you check your own glucose and what readings you normally see.
• Any plan to change your diabetes medicines in future.

Tell the team who manages your diabetes as well, and ask them how they want you to monitor as the dose increases. If you notice a new symptom after starting or changing dose, speak to your prescriber, and you can report suspected side effects through the Yellow Card scheme.¹⁹

For the broader picture of who needs extra caution, see our guide to who should not take GLP-1 treatments.

05 · Warfarin and narrow-margin drugs

Warfarin and other narrow-margin medicines

Warfarin and other narrow-margin medicines need your prescriber's attention before you start tirzepatide, because small changes in how they are absorbed can matter.¹ A narrow-margin medicine is one where the gap between a helpful dose and a problematic dose is small, so even a modest shift in absorption can change how well it works or how safe it is.

Because tirzepatide slows stomach emptying, oral medicines can reach the bloodstream a little differently, particularly when you start treatment or increase the dose.¹³ For a medicine with a wide safety margin, that rarely matters. For warfarin, it is a reason to tell the person who monitors your treatment that you are starting something new.

Raise it at the start, and again whenever your Mounjaro dose changes.

Things to do if you take warfarin or a similar medicine:

• Tell the consultation about it clearly, with the exact name and dose.
• Tell your anticoagulant clinic or GP surgery that you plan to start tirzepatide.
• Ask how they want you to be monitored during the first weeks and after each dose increase.
• Report any unusual bleeding, bruising or other new symptom promptly.

You may have seen lists that name 'certain blood thinners' as a problem with tirzepatide. That is a fair summary of the caution, but it is not a ban. The correct reading is: this is a medicine group where your prescriber should know and plan, not one where the answer is automatically no.

Other medicines with a similar small safety margin may exist in your regimen. If you are unsure whether something you take counts, ask your pharmacist. A short conversation before you start is far easier than sorting out a problem afterwards.

The same principle applies if a hospital doctor, dentist or another prescriber starts a new medicine while you are on tirzepatide. Say you are taking Mounjaro every time. For related reading, see our guide on which medicines to avoid with Mounjaro.

06 · Contraception and the pill

Oral contraceptives: absorption can be reduced

Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. This applies to the pill only — implants, coils and injections are unaffected.⁷

If you take a contraceptive pill and are starting tirzepatide, raise it in your consultation and with your prescriber. The MHRA has published guidance on contraception with GLP-1 and GIP medicines, and it is the right place to look for current official advice.⁷

The effect matters most when you start treatment or increase the dose, because those are the points when oral medicines may be absorbed differently.¹³

Some people find that other effects of treatment, such as sickness or diarrhoea, add to the concern about whether a pill has been absorbed. If you have vomiting or severe diarrhoea, follow the instructions in your pill's own leaflet and tell your prescriber.

Practical points:

• Tell your prescriber which contraceptive you use, including any non-oral methods.
• Ask which non-oral or barrier method suits you for 4 weeks after starting and for 4 weeks after each dose increase.
• Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.
• Do not stop a contraceptive without advice.

This is one of the interactions most often missed, because it does not involve a medicine for a condition you are being treated for. Telling your prescriber costs nothing and can prevent an unwanted surprise.

Our related guide on medication to avoid with Mounjaro sets the contraceptive point alongside the others, so you can see the full picture on one page.

07 · Other GLP-1 medicines

Other GLP-1 and weight-loss medicines

Mounjaro must not be combined with other GLP-1 medicines, and your prescriber needs to know about any other weight-management treatment you use. These combinations have no safety data and no regulated supply chain.

Tirzepatide already activates the GLP-1 receptor, together with the GIP receptor.¹ Adding semaglutide (Wegovy or Ozempic) or liraglutide would mean layering similar actions on top of each other, and combinations of that kind are unlicensed.

It helps to know how these products differ, so you can recognise a duplicate:

• Mounjaro (tirzepatide) is a once-weekly pen, supplied in six strengths from 2.5mg to 15mg.
• Wegovy (semaglutide) is also once weekly, with pens at 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after at least four weeks.
• Liraglutide (Saxenda, and products such as Erly) is supplied at 6mg per millilitre and is a daily injection, unlike the weekly pens.

If you are moving from one of these to another, the question is not whether to combine them but how to switch, and that is a decision for a prescriber who knows your history. Do not overlap them yourself, and do not keep a spare supply of the old product 'just in case'.

The same applies to newer tablet options.

Also tell your prescriber about any non-prescription weight-loss product you are using. If you are unsure, choose the cautious route and ask. Our guide on who should not take GLP-1 drugs adds more on suitability.

08 · Painkillers, alcohol, supplements

Painkillers, alcohol and supplements

No adjustment is needed for paracetamol.¹

Ibuprofen and other anti-inflammatory painkillers. Ask your prescriber or pharmacist, especially if you have a stomach, kidney or heart condition, or take other regular medicines. A pharmacist can check your whole list in a few minutes.

Alcohol. Because treatment can change how you feel after eating and drinking, and because it sits alongside a reduced-calorie diet, it is sensible to raise your drinking habits with your prescriber and read the patient leaflet.¹³

Vitamins and supplements. Many supplements are not studied alongside tirzepatide, and dosing is not standardised. Treat them like any other medicine: list them, and tell your prescriber. Our guide on vitamins to avoid with Mounjaro covers this in more detail.

A general rule that helps: if a product is taken by mouth and has a real effect on your body, it counts as a medicine for interaction purposes. That includes herbal remedies, 'natural' appetite products and anything marketed as a substitute for prescription treatment. Low-cost supplements with dramatic claims are no replacement for a licensed medicine.

For pain management more broadly, your pharmacist is the right first call. They can suggest options that fit your health history, and they will want to know you are using tirzepatide. If anything new happens after starting a medicine, report it to your prescriber, and you can report suspected side effects through the MHRA Yellow Card scheme.¹⁹

09 · When it may not work

What can make tirzepatide not work as expected

Several practical things can stop tirzepatide working as expected, and most have nothing to do with interactions. The medicine works alongside a reduced-calorie diet and increased physical activity, not instead of them, and results vary from person to person.

Start with the pen itself. Store unopened pens in the fridge, at 2–8°C, until first use, and they keep until the printed expiry date. Once in use, a KwikPen is licensed for up to 30 days (not above 30°C) out of the fridge.¹³ For anything beyond that, such as an unopened pen left out, check the patient information leaflet and speak to the pharmacy. A pen kept outside its tested conditions may no longer have assured sterility and potency, so do not use it on a hunch.

Next, the source. Counterfeit and unregulated products circulate online. The MHRA publishes counterfeit medicine alerts, and you can check any pharmacy on the GPhC register.⁷ Be wary of any seller offering to supply without a consultation or prescription.

Then dose and consistency. If you have questions about a missed dose, ask your prescriber.

Finally, other medicines. Because tirzepatide slows stomach emptying, it can change how oral medicines are absorbed, and the contraceptive pill is the clearest example.⁷ Other medicines may also change how you feel on treatment, so a full review of your list is part of good care.

If you feel that treatment is not working, do not raise the dose yourself or add another product. Speak to your prescriber, who can review adherence, diet, dose and your other medicines. Our ongoing monthly reviews exist for exactly this: dose-titration, follow-up assessments and side-effect support from the prescribing team.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹

11 · Eligibility and NHS access

Who should not take it, and NHS versus private access

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. Our related guides on who should not take Mounjaro and on who should avoid GLP-1 treatments cover eligibility in more depth.

Be ready to tell a prescriber about every condition you have, every medicine you take, any pregnancy plans, and any previous reactions to similar treatments. That is the information that decides suitability.

On access, Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40 and above with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

Whichever route you take, the interaction advice is the same. NHS or private, your prescriber needs your full medicine list. If you move between routes, bring that list with you. Keep a note of your current dose and the date of your last injection.

You can start with our free online consultation when you are ready. This page is information, not a substitute for medical advice.